Watchlist Price Alert

STERIS (STE)

NYSE: STE · Real-Time Price · USD

225.17

2.72 (1.22%)

At close: May 07, 2025, 3:59 PM

221.40

-1.67%

After-hours: May 07, 2025, 05:06 PM EDT

1.22% (1D)

Bid	200
Market Cap	22.12B
Revenue (ttm)	5.4B
Net Income (ttm)	467.59M
EPS (ttm)	6.23
PE Ratio (ttm)	36.14
Forward PE	22.22
Analyst	Buy

Ask	260
Volume	546,994
Avg. Volume (20D)	600,500
Open	223.35
Previous Close	222.45
Day's Range	220.91 - 225.93
52-Week Range	200.98 - 248.24
Beta	0.96

About STE

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol STE

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for STE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

STERIS is scheduled to release its earnings on May 14, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

3 months ago

+3.55%

STERIS shares are trading higher. The company anno... Unlock content with Pro Subscription

6 months ago

-5.28%

Steris shares are trading lower after the company reported worse-than-expected Q2 revenue results

News

25 minutes ago · seekingalpha.com

10 Undervalued Dividend Growth Stocks: May 2025

I rank a selection of undervalued dividend growth stocks in Dividend Radar and present the top ten stocks for consideration. I use two valuation screens, one based on my fair value estimate, and anoth...

1 day ago · zacks.com

Will Applied Sterilization Growth Help STE Beat Q4 Earnings Estimates?

STERIS is expected to have experienced an increase in bioprocessing demand in the fourth quarter.

3 weeks ago · zacks.com

Is it the Right Time to Hold STERIS Stock in Your Portfolio?

STE stays on investors' radars due to the strength of its Healthcare arm and strong rebound potential in the AST segment.

1 month ago · seekingalpha.com

Steris: AST Recovery Is Ongoing; Upgrading To 'Strong Buy'

Upgraded Steris to 'strong buy' with a fair value of $254 per share due to strong recovery in its Applied Sterilization Technologies (AST) business. AST segment showed 9.5% organic growth, with manage...